Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Barbituric acid

Base Information Edit
  • Chemical Name:Barbituric acid
  • CAS No.:67-52-7
  • Deprecated CAS:117491-80-2,118738-52-6,154254-45-2,158217-19-7,160336-60-7,16564-27-5,20964-57-2,223674-02-0,32267-40-6,42910-84-9,51159-18-3,53853-41-1,63896-95-7,1194-23-6,253678-06-7,253678-07-8,253678-08-9,408335-37-5,465532-08-5,477705-05-8,678184-94-6,774592-06-2,860760-03-8,888733-51-5,914348-20-2,944357-77-1,1030660-92-4,1175001-15-6,1227251-16-2,1333204-15-1,1351684-07-5,1392108-86-9,1696408-95-3,1802859-89-7,1811546-22-1,1825368-05-5,1888309-80-5,1906914-02-0,2171459-71-3,2258646-20-5,1030660-92-4,1175001-15-6,118738-52-6,1194-23-6,1227251-16-2,1333204-15-1,1351684-07-5,1392108-86-9,154254-45-2,158217-19-7,160336-60-7,16564-27-5,1696408-95-3,1802859-89-7,1811546-22-1,1825368-05-5,20964-57-2,223674-02-0,253678-06-7,253678-07-8,253678-08-9,32267-40-6,408335-37-5,42910-84-9,465532-08-5,477705-05-8,51159-18-3,53853-41-1,63896-95-7,678184-94-6,774592-06-2,860760-03-8,888733-51-5,914348-20-2,944357-77-1
  • Molecular Formula:C4H4N2O3
  • Molecular Weight:128.087
  • Hs Code.:2933.52
  • European Community (EC) Number:200-658-0,224-507-3
  • NSC Number:7889
  • UNII:WQ92Y2793G
  • DSSTox Substance ID:DTXSID8020129
  • Nikkaji Number:J348D
  • Wikipedia:Barbituric_acid
  • Wikidata:Q410278
  • NCI Thesaurus Code:C67084
  • Metabolomics Workbench ID:49568
  • ChEMBL ID:CHEMBL574699
  • Mol file:67-52-7.mol
Barbituric acid

Synonyms:barbiturate;barbituric acid;barbituric acid, monosodium salt;sodium barbiturate

Suppliers and Price of Barbituric acid
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Sigma-Aldrich
  • Barbituric acid for analysis EMSURE
  • 1001320025
  • $ 82.20
  • Sigma-Aldrich
  • Barbituric acid for analysis EMSURE?
  • 25 g
  • $ 78.72
  • Sigma-Aldrich
  • Barbituric acid for synthesis. CAS 67-52-7, pH 2 - 3 (50 g/l, H O, 60 °C)., for synthesis
  • 8001330100
  • $ 54.70
  • Sigma-Aldrich
  • Barbituric acid 99%
  • 100g
  • $ 53.20
  • Sigma-Aldrich
  • Barbituric acid for synthesis
  • 100 g
  • $ 52.35
  • Sigma-Aldrich
  • Barbituric acid 99%
  • 25g
  • $ 32.00
  • Sigma-Aldrich
  • Barbituric acid for analysis EMSURE
  • 1001320100
  • $ 239.00
  • Sigma-Aldrich
  • Barbituric acid for analysis EMSURE?
  • 100 g
  • $ 228.47
  • Sigma-Aldrich
  • Barbituric acid for spectrophotometric det. of cyanide, ≥99.5%
  • 100 g
  • $ 160.00
  • Sigma-Aldrich
  • Barbituric acid for spectrophotometric det. of cyanide, ≥99.5%
  • 100g-f
  • $ 155.00
Total 199 raw suppliers
Chemical Property of Barbituric acid Edit
Chemical Property:
  • Appearance/Colour:cream coloured fine crystalline powder 
  • Vapor Pressure:3.64E-15mmHg at 25°C 
  • Melting Point:248-252 °C (dec.)(lit.) 
  • Refractive Index:1.581 
  • Boiling Point:260 °C 
  • PKA:4.01(at 25℃) 
  • Flash Point:150 °C 
  • PSA:75.27000 
  • Density:1.455 g/cm3 
  • LogP:-0.59990 
  • Storage Temp.:Store below +30°C. 
  • Solubility.:11.45g/l 
  • Water Solubility.:142 g/L (20 ºC) 
  • XLogP3:-1.5
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:3
  • Rotatable Bond Count:0
  • Exact Mass:128.02219199
  • Heavy Atom Count:9
  • Complexity:168
Purity/Quality:

99% *data from raw suppliers

Barbituric acid for analysis EMSURE *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
  • Statements: 36/37/38 
  • Safety Statements: 24/25 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Chemical Classes:Nitrogen Compounds -> Pyrimidines
  • Canonical SMILES:C1C(=O)NC(=O)NC1=O
  • Description Barbiturates are derivatives of barbituric acid, barbituric acid is formed by the condensation of malonic acid and urea, itself has no anesthetic effect, but if its C2 and C5 atoms are substituted by different genes, it can generate many species of barbiturate agents ,for example, oxygen of C2 is replaced by sulfur, which generates sulfur barbiturates, such as thiopental. Barbiturates'mechanism is basically the same, they act on different levels of the central nervous system, and have a non-specific inhibition. Its sedative and hypnotic effects may be related to selective inhibition of thalamic reticular upstream activating system , thereby blocking the excite transduction to cerebral cortex. Its Anticonvulsant effect is performed through inhibiting synaptic transmission in the central nervous system ,to improve the electrical stimulation threshold in motor cortex.barbiturates having a therapeutic effect play a inhibiting role in the central nervous system , such as phenobarbital (phenobarbitone), amobarbital (amylobarbitone), thiopental , methohexital (methohexi-tone ). Inhibitory barbiturates have sedative, hypnotic, anticonvulsant and anesthetic effects, but its sedative-hypnotic agent has been eliminated, because in the process it is easy to produce severe tolerance, drug dependence and drug liver enzyme induction.Because of some differences in their chemical structure, the body eliminate and fat-soluble manner of every drug are different , thus the speed of appearing effect and time of continuing also vary . Long-acting barbiturates such as phenobarbital (phenobarbi-tone) are still used in the treatment of epilepsy anticonvulsant. Ultrashort acting barbiturates (thiopental and methohexital) are often applied as an intravenous anesthetic.Barbiturate intravenous anesthetics used clinically are now about ten kinds, but three to five species are commonly used . According to the view of Anesthesiology, barbiturates can be divided into two categories, namely hypnotic barbiturates and barbiturate anesthesia. The former are markedly slower drugs such as phenobarbital,having a sedative effect, before anesthesia,its administration can make the patient quiet. After intravenous injection of the latter, consciousness soon disappear,it is mainly used for general anesthesia, in which the most commonly used drug is thiopental, so this drug is representative.Phenobarbital is a barbituric acid derivative, having weak acid,it is the central inhibitor, mainly inhibiting brain ascending reticular activating system. The shallow to deep degree of inhibition of the drug are due to the amount of small to large ,it has different levels of sedative, hypnotic and anticonvulsant, anesthetic effect. In addition, the drug also has antiepileptic effect.The above information is edited by the lookchem of Tian Ye.
  • Uses Barbituric acid is widely used in the manufacturing of plastics, textiles, polymers and pharmaceuticals. It is an active ingredient in the production of Vitamin B2. It is a strong acid in an aqueous medium with an active methylene group involved Knoevenegal condensation. It is used as precursor for the preparation of 5-arylidene barbituric acid by reacting with aromatic aldehyde. It is also used in electrochemical oxidation of iodine using cyclic voltammetry and controlled potential coulometry.
Technology Process of Barbituric acid

There total 78 articles about Barbituric acid which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With quinolinium monofluorochromate(VI); In acetonitrile; for 1.5h; Heating;
Guidance literature:
With sodium; In ethanol; for 7h; Reflux;
DOI:10.1021/acs.joc.6b00640
Guidance literature:
With acetic anhydride; acetic acid; at 90 ℃; for 3h;
DOI:10.1080/07328300601039328
Refernces Edit

Nano-sawdust-OSO3H as a new, cheap and effective nanocatalyst for one-pot synthesis of pyrano[2,3-d]pyrimidines

10.1007/s13738-015-0655-3

The research focuses on the development of a novel, cost-effective nanocatalyst, nano-sawdust-OSO3H, for the one-pot synthesis of biologically important pyrano[2,3-d]pyrimidines, which are known for their potential pharmaceutical applications such as antibacterial, antitumor, and analgesic activities. The experiments involved the use of reactants like barbituric acid or thiobarbituric acid, malononitrile, and a variety of aldehydes. The nanocatalyst was prepared by treating sawdust with chlorosulfonic acid, resulting in particles below 100 nm as observed through SEM imaging. The catalyst's morphology, chemical composition, thermal stability, and surface acidity were analyzed using techniques such as SEM, EDX, TGA/DTG, and FT-IR spectroscopy. The study demonstrated that nano-sawdust-OSO3H is an efficient catalyst, offering excellent yields in short reaction times and with mild reaction conditions, aligning with the principles of green chemistry.

Discovery of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, a readily available and orally active glitazone for the treatment of concanavalin A-induced acute liver injury of BALB/c mice

10.1021/jm901183d

The research focuses on the discovery of a novel glitazone, (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione, as an orally active and readily available treatment for Concanavalin A-induced acute liver injury in BALB/c mice. The study involves the synthesis and screening of 53 small molecules from a small-molecule library, using a quick screening method to evaluate their potency in inhibiting chemotaxis of RAW264.7 cells stimulated by monocyte chemoattractant protein 1 (MCP-1). The most effective compounds were identified through in vitro inhibitory effects and further assessed in vivo for their hepatoprotective effects. The experiments utilized various reactants, including aromatic aldehydes, β-alanine, barbituric acid, thiobarbituric acid, and other chemical reagents, and employed techniques such as Knoevenagel reaction, Wittig reaction, and HPLC for compound synthesis and purity analysis. The biological activity was assessed through chemotaxis assays, serum aminotransferase level measurements, and histopathological evaluations. The study demonstrated that compound 4f significantly reduced serum levels of alanine aminotransaminase (ALT) and asparate aminotransaminase (AST) and showed hepatoprotective effects in the liver injury model, with minimal toxicity observed in histopathological assessments of major organs.

Some Naphthyl Derivatives of Barbituric Acid

10.1021/ja01334a060

The study explores the synthesis and properties of various naphthyl derivatives of barbituric acid. The research focuses on creating compounds where the naphthyl group is either directly attached to the 5-carbon atom or connected via methylene groups. The chemicals involved include a-naphthylmethyl bromide and a-naphthylethyl bromide, which were used for alkylation to introduce naphthylmethyl and naphthylethyl groups into barbituric acids. The study also utilized alkyl barbituric acids, sodium acetate, and urea in the synthesis processes. The goal was to investigate the potential therapeutic properties of these derivatives as sedatives and hypnotics, similar to known compounds like barbital and amytal. The study reports the successful synthesis of several derivatives, including 5,5-ethyl-a-naphthylmethylbarbituric acid, 5,5-n-butyl-a-naphthylmethylbarbituric acid, and 5,5-allyl-a-naphthylmethylbarbituric acid, among others. However, none of the synthesized compounds exhibited desirable physiological effects comparable to barbital or amytal. The study also details the preparation methods and the physical and analytical data of the synthesized compounds.

Synthesis of new azocompounds and fused pyrazolo[5,1-c][1,2,4]triazines using heterocyclic components

10.1002/jhet.1533

The study, titled "Synthesis of New Azocompounds and Fused Pyrazolo[5,1-c][1,2,4]triazines Using Heterocyclic Components," investigates the synthesis of new azocompounds and tricyclic pyrazolo[5,1-c][1,2,4]triazines using various heterocyclic components. The key chemical involved is 3-methyl-4-phenyl-1H-pyrazol-5-amine, which is diazotized to form pyrazole-3(5)-diazonium chloride. This diazonium salt undergoes azocoupling reactions with a variety of heterocyclic compounds, including barbituric acid, thiobarbituric acid, 2-hetarylpyrimidine-4,6-diones, 4-hydroxy-6-methylpyridin-2(1H)-one, 4-hydroxy-6-methyl-2H-pyran-2-one, 4-hydroxy-1-p-tolyl-1H-pyrazole-3-carboxylic acid ethyl ester, 1,3-thiazolidine-2,4-dione, and 2-thioxo-1,3-thiazolidin-4-one. These reactions yield new pyrazolylazo derivatives and fused pyrazolo[5,1-c][1,2,4]triazines through subsequent heterocyclization processes. The study explores the synthetic potential of these heterocyclic components in azocoupling reactions, highlighting their potential applications in industrial azo dyes, analytical indicators, and bioactive compounds related to purines.

Convergent domino Knoevenagel hetero-Diels-Alder and domino oxidation hetero-Diels-Alder reactions encountered in an unexpected formation of novel 5-aryl-1H-pyrano[2,3-d]pyrimidine-2,4(3H,5H)-diones and 5-aryl-2,3-dihydro-2- thioxo-1H-pyrano[2,3-d]pyrimid

10.1002/hlca.201000325

The research explores the novel synthesis of 5-aryl-1H-pyrano[2,3-d]pyrimidine-2,4(3H,5H)-diones and their 2-thioxo analogs through convergent domino Knoevenagel hetero-Diels-Alder and domino oxidation hetero-Diels-Alder reactions. The purpose of this study is to develop a one-pot synthetic strategy for these compounds, which have significant biological activities, including antiviral, antibacterial, and antifungal properties. Barbituric acid is a key component in the Knoevenagel condensation step. It reacts with various benzaldehyde derivatives to form 5-arylidenebarbituric acid derivatives (II). These derivatives are essential intermediates that act as dienes in the subsequent hetero-Diels-Alder reaction. 2-Thiobarbituric acid is used similarly to barbituric acid but introduces a sulfur atom into the structure, leading to the formation of 2-thioxo analogs of the target compounds. Like barbituric acid, it undergoes Knoevenagel condensation with benzaldehydes to form the corresponding 5-arylidene derivatives. Both barbituric acid and 2-thiobarbituric acid are essential for generating the dienes required for the hetero-Diels-Alder reaction. Their ability to form reactive intermediates and participate in multiple reaction pathways is critical for the success of the convergent domino reactions described in the study.

Chemical modification of plant alkaloids. I. Aminomethylation of barbituric acid derivatives by cytisine

10.1007/BF02236429

The study focuses on the chemical modification of plant alkaloids, specifically the aminomethylation of barbituric acid derivatives by cytisine. The researchers used cytisine, a plant alkaloid found in the seeds of certain plants, and barbituric acid derivatives to synthesize new compounds with potential biological activity. The purpose of these modifications is to create new cytisine derivatives that could have applications in medicine, particularly as respiratory analeptics and central nervous system regulators, given the physiological activities of cytisine and its synthetic derivatives. The study details the synthesis process, which involves the reaction of cytisine with 1-mono- and 1,3-disubstituted 5-arylmethylbarbituric acids in the presence of formaldehyde, leading to the formation of 5-cytisylmethylbarbituric acids. The structures of these products were confirmed using PMR spectroscopy and mass spectrometry, and the study also discusses the stereoselectivity of the reaction and the potential pharmaceutical applications of the synthesized compounds.

10.1021/ja01299a015

The study focuses on the preparation and pharmacological investigation of di- and trialkyl barbituric acids. The researchers synthesized various malonic esters by reacting alkyl halides with sodiomalonic ester or sodioalkylmalonic ester, and then used these esters to prepare barbituric acids by condensing them with urea, methyl urea, or ethyl urea in the presence of sodium ethoxide. The barbituric acids were purified by recrystallization or fractional distillation. The study also involved converting these acids into their sodium salts and testing their pharmacological effects on laboratory animals, primarily white rats. The results indicated that the introduction of a third alkyl group generally lessened the duration of action, and in some cases, alkylating the nitrogen group made the barbituric acids less effective. The study provides insights into the relationship between the chemical structure of barbituric acids and their pharmacological properties.

Post RFQ for Price